R
Richard Duszak
Researcher at Emory University
Publications - 391
Citations - 5265
Richard Duszak is an academic researcher from Emory University. The author has contributed to research in topics: Medicine & Health care. The author has an hindex of 32, co-authored 356 publications receiving 4173 citations. Previous affiliations of Richard Duszak include Hospital of the University of Pennsylvania & Carolinas Medical Center.
Papers
More filters
Journal ArticleDOI
Preventing Another Group From Displacing Your Practice: Perspectives From the 2010 AMCLC
TL;DR: A number of strategies to maintain and foster long-term service relationships were discussed by the ACR Council and are reviewed herein.
Journal ArticleDOI
Bacterial Contamination of Radiologist Workstations: Results of a Pilot Study
TL;DR: Bacterial contamination of microphones and computer mice at radiologist workstations is common, with colonization significantly greater than nearby restroom toilet seats and doorknobs and simple, rapid, and inexpensive disinfection techniques nearly completely eradicate workstation bacterial contamination.
Journal ArticleDOI
Business Intelligence, Data Mining, and Future Trends
TL;DR: Metrics and data necessary to monitor performance in the new outcomeand value-driven domain are discussed and how such business intelligence can inform strategy, design, and implementation of Imaging 3.0 are outlined.
Journal ArticleDOI
Expert witness blinding strategies to mitigate bias in radiology malpractice cases: a comprehensive review of the literature.
Daniel J. Durand,Christopher T. Robertson,Gautam Agarwal,Richard Duszak,Elizabeth A. Krupinski,Jason N. Itri,Anthony F. Fotenos,Brent Savoie,Alexander Ding,Jonathan S. Lewin +9 more
TL;DR: The purpose is to acquaint the reader with the evidence that unblinded expert-witness testimony is tainted by multiple sources of bias and to examine proposed strategies for addressing these biases through blinding.
Journal ArticleDOI
Digital Breast Tomosynthesis Implementation: Considerations for Emerging Breast Cancer Screening Bundled Payment Models.
Margaret M. Fleming,Danny R. Hughes,Lauren Parks Golding,Geraldine McGinty,Dan MacFarlane,Richard Duszak +5 more
TL;DR: Prior non-DBT approaches to bundled payment models for breast cancer screening remain viable as DBT becomes the standard of care, with bundle prices varying little by patient age, race, or insurance status, but higher DBT-inclusive bundled prices highlight the need to explore societal costs more broadly.